Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Apply
KK2223
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step